Regulatory Impact on Medical Devices - An Interview with Chuck Sidebottom
With over 30 years in the industry, Chuck Sidebottom Director of Corporate Standards at Medtronic is excellently placed to analyse trends in the medical device industry. When he spoke with Pharma IQ, Chuck discussed recent shifts in regulatory emphasis and predicted how this emphasis will change in the future. He also discussed the importance of and difficulties involved in instilling a culture of compliance across multiple offices and in multiple jurisdictions.
To continue reading this story get free access